This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Porcine Peptidyl Arginine Deiminase Type II (PADI2) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for peptidyl arginine deiminase type II. It is affinity purified by protein A. It can be applied to WB, IF, IHC and ELISA assays of peptidyl arginine deiminase type II.
Specifications
Target Information
Porcine peptidyl arginine deiminase type II (PADI2) is an enzyme that belongs to the peptidylarginine deiminase family, which is involved in the process of citrullination. This post-translational modification involves the conversion of arginine residues to citrulline within proteins, a process that can alter protein structure and function, impacting various biological processes. PADI2 is particularly significant in the context of the immune response, as citrullination can affect antigen presentation and modulate the activity of immune cells. It is also implicated in the pathogenesis of certain autoimmune diseases, such as rheumatoid arthritis, where the presence of citrullinated proteins can trigger an immune response.
Shipping and Storage
This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Beato, Miguel, et al. "Peptidyl arginine deiminase 2 (PADI2)-mediated arginine citrullination modulates transcription in cancer." International journal of molecular sciences 21.4 (2020): 1351.